ArticleACS omega2026
Defining Operational Limits of Low-Cost MSLA 3D Printing for Microfluidic Systems: Resin Performance, Cell Compatibility, and Fluid Dynamics.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Additive manufacturing using low-cost masked stereolithography technology is an attractive option to democratize microfluidic devices fabrication, albeit with limits in spatial resolution, optical transparency, cytotoxicity, and replication that need to be addressed. In this work, five transparent masked stereolithography resins employed in an Anycubic Photon M7 Pro low-cost printer are systematically studied to address the limitations mentioned above. The working route was based on the analysis of the dimensions of negative and positive microfeatures, their transmission spectra, their cytotoxicity, the capability of building internal channels, replicability in PDMS, and validation by computational fluid dynamics simulations with experimental fluid assays. Resolution tests revealed that negative structures resolved less accurately due to subtle resin accumulation during the layer-by-layer printing process. Internal channel fabrication showed a practical lower limit of approximately 500 μm under the printing and postprocessing conditions used in the study, with resin viscosity, printing angle, and drainage behavior strongly influencing channel clearance. The Standard V2 and High Clear resins exhibited the highest printing resolution with microchannels printed in a vertical or almost-vertical position. Regarding thermally cured PDMS replication, the Tough Ultra, ABS-like Pro 2, and Water-Wash were the ones exhibiting the most accurate outcome. From a biological point of view, all resins were non-cytotoxic, with Standard V2 and High Clear exhibiting the highest cell viability, in some cases better than the control scenario. Contact angle measurements indicated that the Standard V2 and High Clear resins are highly hydrophilic, whereas the remaining resins exhibit a hydrophobic behavior. Swelling was found to be dependent on the media, where the Water-Wash found high swelling in Milli-Q water and PBS and the Tough Ultra in ethanol. Samples were only minimally affected by isopropyl alcohol. Finally, fluid flow assays were conducted on three different microfluidic chips to demonstrate that the introduction of microfeatures and zigzag architectures fosters the disruption of laminar flow conditions by introducing secondary flows and vorticity to mimic more physiological environments. These experiments were contrasted with simulations performed by computational fluid dynamics. It was verified that microfeatures can be adequately implemented in the chip architecture and result in enhanced mixing. This validation allowed defining a practical operating window for MSLA 3D printers for microfluidics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.